title: [Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
authors.affiliation: Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo.
authors.forename: Masaaki
authors.initials: M
authors.lastname: Matsushima
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Yaguchi
authors.forename: Riichiro
authors.initials: R
authors.lastname: Kishimoto
authors.forename: Sachiko
authors.initials: S
authors.lastname: Tsuji
authors.forename: Ichiro
authors.initials: I
authors.lastname: Yabe
authors.forename: Hidenao
authors.initials: H
authors.lastname: Sasaki
authors.forename: Megumi
authors.initials: M
authors.lastname: Nakadate
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Shiraishi
authors.forename: Masakatsu
authors.initials: M
authors.lastname: Motomura
mesh_terms: D015761:4-Aminopyridine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077770:Amifampridine; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications* / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011729:Pyridostigmine Bromide / Q000008:administration & dosage; D016896:Treatment Outcome